Portfolio Holdings Detail for ISIN IE00BYZK4552
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / FundiShares Automation & Robotics UCITS ETF USD (Acc)
IssuerBlackrock
ETF TickerRBTX(GBX) LSE
ETF Ticker2B76(EUR) F
ETF Ticker2B76.DE(EUR) CXE
ETF TickerRBOE.AS(EUR) CXE
ETF TickerRBOT.LS(USD) CXE
ETF TickerRBOT.MI(EUR) CXE
ETF TickerRBOTz(USD) CXE
ETF TickerRBTX.LS(GBX) CXE
ETF TickerRBOE(EUR) Euronext Amsterdam
ETF TickerRBOT(EUR) ETF Plus
ETF TickerRBTX.L(GBP) LSE

Holdings detail for MLAB

Stock NameMesa Laboratories Inc
TickerMLAB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS59064R1095
LEI549300ZCG738WLX8ZW79

Show aggregate MLAB holdings

News associated with MLAB

Implied VIOO Analyst Target Price: $124
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:09:35
Choreo LLC Decreases Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Choreo LLC lowered its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 3.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,887 shares of the medical instruments supplier’s stock after selling 165 shares during the quarter. Choreo LLC owned 0.09% […] - 2025-07-28 05:46:54
Bank of New York Mellon Corp Boosts Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Bank of New York Mellon Corp lifted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 2.7% during the first quarter, Holdings Channel reports. The institutional investor owned 54,767 shares of the medical instruments supplier’s stock after acquiring an additional 1,463 shares during the quarter. Bank of New York Mellon Corp’s holdings in […] - 2025-07-24 04:20:52
Mesa Laboratories (NASDAQ:MLAB) Downgraded by Wall Street Zen to “Buy”
Wall Street Zen lowered shares of Mesa Laboratories (NASDAQ:MLAB – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Friday morning. Separately, Wells Fargo & Company decreased their price target on Mesa Laboratories from $120.00 to $100.00 and set an “underweight” rating on the stock in […] - 2025-06-02 04:20:57
Ameriprise Financial Inc. Acquires 99,819 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Ameriprise Financial Inc. boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 191.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 151,862 shares of the medical instruments supplier’s stock after purchasing an additional 99,819 shares during the period. Ameriprise Financial Inc.’s holdings in Mesa Laboratories were worth $20,026,000 as of […] - 2025-05-16 05:01:15
Implied IJT Analyst Target Price: $153
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-15 07:40:17
Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP trimmed its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,850 shares of the medical instruments supplier’s stock after selling 9,723 shares during the […] - 2025-05-09 05:02:47
Short Interest in Mesa Laboratories, Inc. (NASDAQ:MLAB) Rises By 20.1%
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 224,300 shares, an increase of 20.1% from the March 31st total of 186,700 shares. Based on an average trading volume of 44,100 shares, the short-interest ratio […] - 2025-05-05 05:30:49
Mesa Laboratories, Inc. (NASDAQ:MLAB) Stake Decreased by CANADA LIFE ASSURANCE Co
CANADA LIFE ASSURANCE Co reduced its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,927 shares of the medical instruments supplier’s stock after selling 577 shares during the quarter. […] - 2025-04-30 05:44:12
Analysts Expect SPTM To Hit $83
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-02 08:02:55
Choreo LLC Grows Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Choreo LLC lifted its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 38.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,052 shares of the medical instruments supplier’s stock after purchasing an additional 1,392 shares during […] - 2025-02-11 06:46:52
Mesa Laboratories (NASDAQ:MLAB) Shares Up 12.3% After Better-Than-Expected Earnings
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price was up 12.3% during mid-day trading on Tuesday after the company announced better than expected quarterly earnings. The stock traded as high as $143.94 and last traded at $150.43. Approximately 4,303 shares changed hands during trading, a decline of 85% from the average daily volume […] - 2025-02-06 04:08:53
Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High After Earnings Beat
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price reached a new 52-week high on Wednesday following a stronger than expected earnings report. The company traded as high as $152.75 and last traded at $137.27, with a volume of 68479 shares traded. The stock had previously closed at $133.93. The medical instruments supplier reported […] - 2025-02-05 04:40:49

iShares Automation & Robotics UCITS ETF USD (Acc) MLAB holdings

DateNumber of MLAB Shares HeldBase Market Value of MLAB SharesLocal Market Value of MLAB SharesChange in MLAB Shares HeldChange in MLAB Base ValueCurrent Price per MLAB Share HeldPrevious Price per MLAB Share Held
2025-10-21 (Tuesday)14,734USD 1,162,807MLAB holding increased by 36540USD 1,162,8070USD 36,540 USD 78.92 USD 76.44
2025-10-20 (Monday)14,734USD 1,126,267MLAB holding increased by 49580USD 1,126,2670USD 49,580 USD 76.44 USD 73.075
2025-10-17 (Friday)14,734USD 1,076,687MLAB holding decreased by -15839USD 1,076,6870USD -15,839 USD 73.075 USD 74.15
2025-10-16 (Thursday)14,734USD 1,092,526MLAB holding increased by 50243USD 1,092,5260USD 50,243 USD 74.15 USD 70.74
2025-10-15 (Wednesday)14,734USD 1,042,283MLAB holding decreased by -10903USD 1,042,2830USD -10,903 USD 70.74 USD 71.48
2025-10-14 (Tuesday)14,734USD 1,053,186MLAB holding increased by 46633USD 1,053,1860USD 46,633 USD 71.48 USD 68.315
2025-10-13 (Monday)14,734USD 1,006,553USD 1,006,553
2025-10-08 (Wednesday)14,734USD 1,042,431USD 1,042,431
2025-10-07 (Tuesday)14,734USD 1,004,859USD 1,004,859
2025-10-06 (Monday)14,734USD 1,060,111USD 1,060,111
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MLAB by Blackrock for IE00BYZK4552

Show aggregate share trades of MLAB

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-06-13SELL-55 97.100* 122.28 Profit of 6,725 on sale
2025-04-16BUY55 112.920* 126.71
2025-04-15SELL-55 115.520* 126.84 Profit of 6,976 on sale
2025-04-08SELL-55 105.235* 127.69 Profit of 7,023 on sale
2025-04-07SELL-55 109.040* 127.91 Profit of 7,035 on sale
2025-04-04SELL-55 108.000* 128.15 Profit of 7,048 on sale
2025-03-25SELL-108 125.420* 128.78 Profit of 13,908 on sale
2025-03-14SELL-55 126.180* 129.05 Profit of 7,098 on sale
2025-03-12SELL-110 123.420* 129.24 Profit of 14,216 on sale
2025-03-11SELL-55 124.710* 129.30 Profit of 7,112 on sale
2025-03-10SELL-53 125.670* 129.36 Profit of 6,856 on sale
2025-02-25SELL-216 144.360* 128.06 Profit of 27,660 on sale
2025-02-19BUY53 150.200* 126.74
2025-01-31SELL-52 137.690* 121.38 Profit of 6,312 on sale
2025-01-23BUY260 142.410* 118.17
2024-12-09SELL-54 131.060* 117.00 Profit of 6,318 on sale
2024-12-05SELL-54 123.000* 116.56 Profit of 6,295 on sale
2024-11-29SELL-108 117.140* 115.73 Profit of 12,499 on sale
2024-11-22SELL-55 109.090* 115.86 Profit of 6,373 on sale
2024-11-05SELL-110 120.810* 118.90 Profit of 13,079 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MLAB

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1950,326068,05274.0%
2025-09-1836,525048,23075.7%
2025-09-1734,714049,66169.9%
2025-09-1634,101065,10052.4%
2025-09-1576,0480143,71952.9%
2025-09-1260,1010101,87159.0%
2025-09-1144,811074,31460.3%
2025-09-1044,12225666,06466.8%
2025-09-0940,070057,00170.3%
2025-09-0860,8490100,07860.8%
2025-09-0521,256044,07648.2%
2025-09-0434,642075,10446.1%
2025-09-0318,550034,66653.5%
2025-09-0214,573029,08950.1%
2025-08-2926,726061,35043.6%
2025-08-2813,200025,93950.9%
2025-08-2711,079017,77362.3%
2025-08-2611,978025,77946.5%
2025-08-2512,753015,62881.6%
2025-08-2224,392036,99665.9%
2025-08-2121,835029,11875.0%
2025-08-2017,748020,40587.0%
2025-08-1916,376020,05681.7%
2025-08-1824,845033,74673.6%
2025-08-1538,699050,73076.3%
2025-08-1428,447041,08769.2%
2025-08-1330,727041,49474.1%
2025-08-1222,059029,87473.8%
2025-08-1133,535044,43975.5%
2025-08-0844,773051,57386.8%
2025-08-0747,023070,94766.3%
2025-08-0666,1382,618116,95256.6%
2025-08-0548,1512,57779,09660.9%
2025-08-0418,085030,00360.3%
2025-08-0132,642144,83472.8%
2025-07-3123,535028,29483.2%
2025-07-3021,088028,52773.9%
2025-07-2913,834020,24168.3%
2025-07-2818,435023,81277.4%
2025-07-2514,516020,18771.9%
2025-07-2432,558042,02777.5%
2025-07-2333,147744,62474.3%
2025-07-2237,85430646,90380.7%
2025-07-2131,176046,12767.6%
2025-07-1833,504056,45959.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.